🛑 Stumble in the middle of the way! US FDA "Brakes" Vaccine Consideration

🛑 Stumble in the middle of the way! The US FDA "brakes" Moderna's 💉 new flu vaccine consideration.

It became big news in the pharmaceutical industry. When the FDA decided "not yet considered," Moderna's request for approval of the new flu vaccine took the expectation of using the mRNA vaccine. The same technology as COVID-19 had to be delayed.

Summary of key points. What happened? 👇

📉 What happened:

Moderna applied for approval of an mRNA technology-based flu vaccine (hoping for a more sensitive and comprehensive manufacturing outcome), but the FDA viewed the documents and data it filed as "not yet meeting the criteria" to enter the next phase of the review process.

❓ Why is it braking?:

Despite analysts seeing the technology as advanced, the main reasons are likely to be:

Missing Data

Results indicators remain unclear (Insufficient Endpoints).

The question of efficacy compared to existing vaccines.

✅ Bad news or just waiting news?

Experts reiterate that "this is not a safety matter." Vaccines are not dangerous, but a matter of "information that needs to be tighter" to be 100% sure before reaching public hands.

Moderna's Next Step: 🚀

The company prepares to collect additional clinical data and will reapply for approval once the evidence is complete.

💡 This reflects that the FDA's safety standards are very stringent. Despite being a major company and how high-tech it is, it must pass through the same rock stage for maximum consumer safety.

💬 What do you think about this? Who's waiting for the mRNA flu vaccine? The comments talk!

# Moderna # Vaccine # FDA # HealthUpdate # Flu vaccine# Health News # Biotech